Pe­di­atric la­bels: FDA ex­pands can­cer and dwarfism drugs from Genen­tech and Bio­Marin

Even younger pe­di­atric pa­tients with sol­id tu­mors or short-limbed dwarfism will now have ac­cess to treat­ment af­ter the FDA ap­proved la­bel ex­pan­sions late Fri­day for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER